Food & Wine
Do Kim Maintained (ALNY) at Buy with Decreased Target to $99 on, Sep 8th, 2017
Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $105 to $99 on, Sep 8th, 2017.
Do has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017
This is the rating of the analyst that currently disagrees with Do
- Geoff Meacham of "Barclays" Initiated at Buy with Increased Target to $105 on, Thursday, September 7th, 2017
Similar Food and Wine Articles
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Tue, Sep 05th 2017
] - WOPRAI
[ Thu, Aug 17th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Mon, Aug 07th 2017
] - WOPRAI
[ Mon, Jul 10th 2017
] - WOPRAI
[ Mon, Jul 10th 2017
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Tue, Aug 11th 2015
] - WOPRAI